RD2-MolPack-Chim3, a Packaging Cell Line for Stable Production of Lentiviral Vectors for Anti-HIV Gene Therapy

Stem cell-based anti-HIV gene therapy

(2011) Scott G. Kitchen et al.   VIROLOGY

Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt

(2011) Ronald T. Mitsuyasu et al.   Stem Cells International

Chim3 confers survival advantage to CD4+ T cells upon HIV-1 infection by preventing HIV-1 DNA integration and HIV-1-induced G2 cell-cycle delay

(2010) S. Porcellini et al.   BLOOD

Transduction of Human Primitive Repopulating Hematopoietic Cells With Lentiviral Vectors Pseudotyped With Various Envelope Proteins

(2010) Yoon-Sang Kim et al.   MOLECULAR THERAPY

Replication-competent Lentivirus Analysis of Clinical Grade Vector Products

(2010) Kenneth Cornetta et al.   MOLECULAR THERAPY

The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration

(2009) S. Porcellini et al.   BLOOD

Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection

(2009) R. E. Throm et al.   BLOOD

Transcriptional Enhancers Induce Insertional Gene Deregulation Independently From the Vector Type and Design

(2009) Giulietta Maruggi et al.   MOLECULAR THERAPY

Cocal-pseudotyped Lentiviral Vectors Resist Inactivation by Human Serum and Efficiently Transduce Primate Hematopoietic Repopulating Cells

(2009) Grant D Trobridge et al.   MOLECULAR THERAPY

Inducible Packaging Cells for Large-scale Production of Lentiviral Vectors in Serum-free Suspension Culture

(2008) Sophie Broussau et al.   MOLECULAR THERAPY

Quantification and Characterization of Autotransduction in Retroviral Vector Producer Cells

(2007) Eva Maria Brandtner et al.   HUMAN GENE THERAPY